Jörn M. Schattenberg

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement”.

Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement

Hepatology(2021)10.1002/hep.31726

N/A

8.0DataRank · unranked

255 citations

Leon A. Adams, Alina M. Allen, Christopher D. Byrne, Yoosoo Chang, Henning Grønbæk +21 more

Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information

PLOS ONE(2024)10.1371/journal.pone.0299487

N/A

0.533DataRank · unranked

34 citations

Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M. Schattenberg, Elisabetta Bugianesi +18 more

Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-Associated Steatohepatitis

Clinical Gastroenterology and Hepatology(2026)10.1016/j.cgh.2025.12.001

N/A

0.241DataRank · unranked

4 citations

Atsushi Nakajima, Elisabetta Bugianesi, Giada Sebastiani, Jörn M. Schattenberg, Leon A. Adams +27 more

Prof Jörn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH)

Expert Opinion on Investigational Drugs(2020)10.1080/13543784.2020.1721150

N/A

0.165DataRank · unranked

2 citations

Jörn M. Schattenberg

The People-First Liver Charter

Nature Medicine(2025)10.1038/s41591-025-03759-8

N/A

0DataRank · unranked

16 citations

Dana Ivancovsky‐Wajcman, Silvana Pannain, Paul Brennan, Melina I. Manolas, Peter Jepsen +35 more

Serum protein risk stratification score for diagnostic evaluation of metabolic dysfunction–associated steatohepatitis

Hepatology Communications(2024)10.1097/hc9.0000000000000586

N/A

0DataRank · unranked

11 citations

Simon T. Dillon, Xuesong Gu, Tina L. Morhardt, Yuyan Xu, Noel Yan‐Ki Chan +14 more

A global action agenda for turning the tide on fatty liver disease

Hepatology(2023)10.1097/hep.0000000000000545

N/A

0DataRank · unranked

91 citations

Henry E. Mark, Alina M. Allen, Juan Pablo Arab, Patrizia Carrieri, Mazen Noureddin +38 more

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Nature Metabolism(2024)10.1038/s42255-024-01043-6

N/A

0DataRank · unranked

237 citations

Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting +83 more

Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum

Journal of Hepatology(2020)10.1016/j.jhep.2020.04.030

N/A

0DataRank · unranked

88 citations

Claudia Filozof, Mazen Noureddin, Mark Berner‐Hansen, Elmer Schabel, Stephanie O. Omokaro +6 more